XF drugs: A new family of antibacterials

Drug News and Perspectives

Volumn 23, Issue 3, 2010, Pages 167-174

  Gonzales, Fernanda Pereira ^a   Maisch, Tim ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5,10,15 TRIS[4 (3 N,N,N TRIMETHYLAMMONIUMPROPOXY)PHENYL] 20 (4 TRIFLUOROMETHYLPHENYL)PORPHYRIN; 5,10,15,20 TETRAKIS(4 N METHYLPYRIDYL)PORPHINE; AMIKACIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; CHLORHEXIDINE; COLISTIN; FULLERENE DERIVATIVE; IMIPENEM; MEROPENEM; NISIN; PHENOTHIAZINE; PHOTOSENSITIZING AGENT; PHTHALOCYANINE DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; PORPHYRIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TIGECYCLINE; TOLONIUM CHLORIDE; UNCLASSIFIED DRUG; VANCOMYCIN; XF 70; XF 73;

ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATION; DRUG APPROVAL; DRUG STRUCTURE; ENTEROBACTER; ENTEROCOCCUS FAECIUM; HOSPITAL INFECTION; HUMAN; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NONHUMAN; PHOTOSENSITIZATION; PHOTOTOXICITY; PSEUDOMONAS AERUGINOSA; REVIEW; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS; BACTERIUM; CROSS INFECTION; DRUG DELIVERY SYSTEM; DRUG DESIGN;

ANTI-BACTERIAL AGENTS; BACTERIA; CROSS INFECTION; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; PHOTOSENSITIZING AGENTS;

EID: 77953600866     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2010.23.3.1444225     Document Type: Review

References (63)

1. Arias, C.A., Murray, B.E. Antibiotic-resistant bugs in the 21st century - a clinical super-challenge. N Engl J Med 2009, 360(5): 439-43.
2. Rice, L.B. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis 2008, 197(8): 1079-81.
3. Zeana, C., Larson, E., Sahni, J. et al. The epidemiology of multidrug-resistant Acinetobacter baumannii: does the community represent a reservoir? Infect Control Hosp Epidemiol 2003, 24 (4): 275-9.
4. Melamed, R., Greenberg, D., Porat, N. et al. Successful control of an Acinetobacter baumannii outbreak in a neonatal intensive care unit. J Hosp Infect 2003, 53(1): 31-8.
5. Taccone, F.S., Rodriguez-Villalobos, H., De Backer, D. et al. Successful treatment of septic shock due to pan-resistant Acinetobacter baumannii using combined antimicrobial therapy including tigecycline. Eur J Clin Microbiol Infect Dis 2006, 25(4): 257-60.
6. Spellberg, B. Antibiotic resistance and antibiotic development. Lancet Infect Dis 2008, 8(4): 211-2.
7. Spellberg, B., Powers, J.H., Brass, E.P., Miller, L.G., Edwards, J.E., Jr., Trends in antimicrobial drug development: implications for the future. Clin Infect Dis 2004, 38(9): 1279-86.
8. Kresken, M., Hafner, D., Schmitz, F.J., Wichelhauf, T.A., PEG-Resistenzstudie 2007: Resistenzsituation bei klinisch wichtigen Infektionserregern gegenüber Antibiotika in Deutschland und im mitteleuropäischen Raum. Antiinfectives Intelligence Gesellschaft für klinisch-mikrobiologische Forschung und Kommunikation mbH 2007, Rheinbach: Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. Arbeitsgemeinschaft Empfindlichkeitsprüfungen & Resistenz.
9. Klevens, R.M., Edwards, J.R., Tenover, F.C. et al. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis 2006, 42(3): 389-91.
10. Sievert, D.M., Rudrik, J.T., Patel, J.B. et al. Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. Clin Infect Dis 2008, 46(5): 668-74.
11. Finks, J., Wells, E., Dyke, T.L. et al. Vancomycin-resistant Staphylococcus aureus, Michigan, USA, 2007. Emerg Infect Dis 2009, 15(6): 943-5.
12. The European Antimicrobial Resistance Surveillance System (EARSS) Annual Report 2007. http://www.rivm.nl/earss/Images/EARSS%202007-FINAL-tcm61-55933.pdf. Accessed April 5, 2010.
13. Resch, A., Wilke, M., Fink, C. The cost of resistance: incremental cost of methicillin-resistant Staphylococcus aureus (MRSA) in German hospitals. Eur J Health Econ 2009, 10(3): 287-97.
14. Kim, T., Oh, P.I., Simor, A.E. The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals. Infect Control Hosp Epidemiol 2001, 22(2): 99-104. (Pubitemid 32157160)
15. Payne, D.J., Gwynn, M.N., Holmes, D.J., Pompliano, D.L. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov 2007, 6(1): 29-40.
16. Ooi, N., Miller, K., Hobbs, J. et al. XF-73, a novel antistaphylococcal membrane-active agent with rapid bactericidal activity. J Antimicrob Chemother 2009, 64(4): 735-40.
17. Kolter, R., Siegele, D.A., Tormo, A. The stationary phase of the bacterial life cycle. Annu Rev Microbiol 1993, 47: 855-74. (Pubitemid 23302955)
18. Patel, R. Biofilms and antimicrobial resistance. Clin Orthop Relat Res 2005(437): 41-7.
19. Anderl, J.N., Zahller, J., Roe, F., Stewart, P.S., Role of nutrient limitation and stationary-phase existence in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother 2003, 47(4): 1251-6.
20. Ooi ,N., Miller, K., Randall, C. et al. XF-70 and XF-73, novel antibacterial agents active against slow-growing and non-dividing cultures of Staphylococcus aureus including biofilms. J Antimicrob Chemother 2010, 65(1): 72-78.
21. Demidova, T.N., Hamblin, M.R., Photodynamic therapy targeted to pathogens. Int J Immunopathol Pharmacol 2004, 17(3): 245-54.
22. Hamblin, M.R., Hasan, T. Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem Photobiol Sci 2004, 3(5): 436-50.
23. Konopka, K., Goslinski, T. Photodynamic therapy in dentistry. J Dent Res 2007, 86(8): 694-707.
24. Nitzan, Y., Dror, R., Ladan, H. et al. Structure-activity relationship of porphines for photoinactivation of bacteria. Photochem Photobiol 1995, 62(2): 342-7.
25. Minnock, A., Vernon, D.I., Schofield, J. et al. Photoinactivation of bacteria. Use of a cationic water-soluble zinc phthalocyanine to photoinactivate both gram-negative and gram-positive bacteria. J Photochem Photobiol B 1996, 32(3): 159-64.
26. Soukos, N.S., Hamblin, M.R., Hasan, T. The effect of charge on cellular uptake and phototoxicity of polylysine chlorin(e6) conjugates. Photochem Photobiol 1997, 65(4): 723-9.
27. Maisch, T., Wagner, J., Papastamou, V. et al. Combination of 10% EDTA, Photosan, and a blue light hand-held photopolymerizer to inactivate leading oral bacteria in dentistry in vitro. J Appl Microbiol 2009, 107(5): 1569-78.
28. Sharma, M., Visai, L., Bragheri, F. et al. Toluidine blue-mediated photodynamic effects on staphylococcal biofilms. Antimicrob Agents Chemother 2008, 52(1): 299-305.
29. Reddi, E., Ceccon, M., Valduga, G. et al. Photophysical properties and antibacterial activity of meso-substituted cationic porphyrins. Photochem Photobiol 2002, 75(5): 462-70.
30. Soukos, N.S., Ximenez-Fyvie, L.A., Hamblin, M.R., Socransky, S.S., Hasan T. Targeted antimicrobial photochemotherapy. Antimicrob Agents Chemother 1998, 42(10): 2595-601.
31. Caminos, D.A., Spesia, M.B., Durantini, E.N., Photodynamic inactivation of Escherichia coli by novel meso-substituted porphyrins by 4-(3-N,N,N- trimethylammoniumpropoxy)phenyl and 4-(trifluoromethyl)phenyl groups. Photochem Photobiol Sci 2006, 5(1): 56-65.
32. Maisch, T., Bosl, C., Szeimies, R.M., Lehn, N., Abels C. Photodynamic effects of novel XF porphyrin derivatives on prokaryotic and eukaryotic cells. Antimicrob Agents Chemother 2005, 49(4): 1542-52.
33. Khoury, A.E., Lam, K., Ellis, B., Costerton J.W. Prevention and control of bacterial infections associated with medical devices. Asaio J 1992, 38(3): M174-8.
34. Maisch, T., Bosl, C., Szeimies, R.M., Love, B., Abels C. Determination of the antibacterial efficacy of a new porphyrin-based photosensitizer against MRSA ex vivo. Photochem Photobiol Sci 2007, 6(5): 545-51.
35. Fux, C.A., Costerton, J.W., Stewart, P.S., Stoodley P. Survival strategies of infectious biofilms. Trends Microbiol 2005, 13(1): 34-40.
36. de Beer, D., Stoodley, P., Lewandowski, Z. Measurement of local diffusion coefficients in biofilms by microinjection and confocal microscopy. Biotechnol Bioeng 1997, 53(2): 151-8.
37. Hall-Stoodley, L., Nistico, L., Sambanthamoorthy, K. et al. Characterization of biofilm matrix, degradation by DNase treatment and evidence of capsule downregulation in Streptococcus pneumoniae clinical isolates. BMC Microbiol 2008, 8: 173.
38. Kaplan, J.B. Therapeutic potential of biofilm-dispersing enzymes. Int J Artif Organs 2009, 32(9): 545-54.
39. Kaplan, J.B., Ragunath, C., Velliyagounder, K., Fine, D.H., Ramasubbu, N., Enzymatic detachment of Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother 2004, 48(7): 2633-6.
40. Wainwright, M., Phoenix, D.A., Laycock, S.L., Wareing, D.R., Wright, P.A., Photobactericidal activity of phenothiazinium dyes against methicillin-resistant strains of Staphylococcus aureus. FEMS Microbiol Lett 1998, 160(2): 177-81.
41. Zolfaghari, P.S., Packer, S., Singer, M. et al. In vivo killing of Staphylococcus aureus using a light-activated antimicrobial agent. BMC Microbiol 2009, 9: 27.
42. Soncin, M., Fabris, C., Busetti, A. et al. Approaches to selectivity in the Zn(II)-phthalocyanine-photosensitized inactivation of wildtype and antibiotic-resistant Staphylococcus aureus. Photochem Photobiol Sci 2002, 1(10): 815-9.
43. Nitzan, Y., Gutterman, M., Malik, Z., Ehrenberg, B. Inactivation of gram-negative bacteria by photosensitized porphyrins. Photochem Photobiol 1992, 55(1): 89-96.
44. Tegos, G.P., Demidova, T.N., Arcila-Lopez, D. et al. Cationic fullerenes are effective and selective antimicrobial photosensitizers. Chem Biol 2005, 12(10): 1127-35.
45. Beveridge, T.J. Use of the gram stain in microbiology. Biotech Histochem 2001, 76(3): 111-8.
46. Livermore, D.M., Antibiotic uptake and transport by bacteria. Scand J Infect Dis Suppl 1990, 74: 15-22.
47. Ferro, S., Ricchelli, F., Mancini, G., Tognon, G., Jori, G. Inactivation of methicillin-resistant Staphylococcus aureus (MRSA) by liposome-delivered photosensitising agents. J Photochem Photobiol B 2006, 83(2): 98-104.
48. Ferro, S., Ricchelli, F., Monti, D., Mancini, G., Jori, G. Efficient photoinactivation of methicillin-resistant Staphylococcus aureus by a novel porphyrin incorporated into a polycationic liposome. Int J Biochem Cell Biol 2007, 39(5): 1026-34.
49. Boyle-Vavra, S., Labischinski, H., Ebert, C.C., Ehlert, K., Daum R.S. A spectrum of changes occurs in peptidoglycan composition of glycopeptide- intermediate clinical Staphylococcus aureus isolates. Antimicrob Agents Chemother 2001, 45(1): 280-7.
50. Pfeltz, R.F., Singh, V.K., Schmidt, J.L. et al. Characterization of passage-selected vancomycin-resistant Staphylococcus aureus strains of diverse parental backgrounds. Antimicrob Agents Chemother 2000, 44(2): 294-303.
51. Rhys-Williams, W., Love, W., Hayter, I. et al. XF-73: a novel antimicrobial - Investigation of the change in MIC against multiple MRSA strains during a 55-passage study. Clin Microbiol Infect 2008, 14(s7): s130.
52. Grinholc, M., Szramka, B., Kurlenda, J., Graczyk, A., Bielawski, K.P. Bactericidal effect of photodynamic inactivation against methicillin-resistant and methicillin-susceptible Staphylococcus aureus is strain-dependent. J Photochem Photobiol B 2008, 90(1): 57-63.
53. Schafer, M., Schmitz, C., Horneck, G., High sensitivity of Deinococcus radiodurans to photodynamically-produced singlet oxygen. Int J Radiat Biol 1998, 74(2): 249-53.
54. Bronshtein, I., Afri, M., Weitman, H. et al. Porphyrin depth in lipid bilayers as determined by iodide and parallax fluorescence quenching methods and its effect on photosensitizing efficiency. Biophys J 2004, 87(2): 1155-64.
55. Redmond, R.W., Kochevar, I.E., Spatially resolved cellular responses to singlet oxygen. Photochem Photobiol 2006, 82(5): 1178-86.
56. Dahl, T.A., Midden, W.R., Hartman, P.E. Comparison of killing of gram-negative and gram-positive bacteria by pure singlet oxygen. J Bacteriol 1989, 171(4): 2188-94.
57. Tsiodras, S., Gold, H.S., Sakoulas, G. et al. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 2001, 358(9277): 207-8.
58. Raghavendra, M., Koregol, A., Bhola, S. Photodynamic therapy: a targeted therapy in periodontics. Aust Dent J 2009, 54(Suppl 1): S102-9.
59. Atieh, M.A. Photodynamic therapy as an adjunctive treatment for chronic periodontitis: a meta-analysis. Lasers Med Sci 2009, Advance publication.
60. Wilson, M., Yianni C. Killing of methicillin-resistant Staphylococcus aureus by low-power laser light. J Med Microbiol 1995, 42(1): 62-6.
61. Valduga, G., Breda, B., Giacometti, G.M., Jori, G., Reddi E. Photosensitization of wild and mutant strains of Escherichia coli by mesotetra (N-methyl-4-pyridyl)porphine. Biochem Biophys Res Commun 1999, 256(1): 84-8.
62. Tegos, G.P., Anbe, M., Yang, C. et al. Proteasestable polycationic photosensitizer conjugates between polyethyleneimine and chlorin(e6) for broad-spectrum antimicrobial photoinactivation. Antimicrob Agents Chemother 2006, 50(4): 1402-10.
63. Spellberg, B., Guidos, R., Gilbert, D. et al. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis 2008, 46(2): 155-64.